BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17219964)

  • 1. CD4+CD25high regulatory cells in peripheral blood of NSCLC patients.
    Liu L; Yao J; Ding Q; Huang S
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(5):548-51. PubMed ID: 17219964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [CD4+CD25high regulatory cells in peripheral blood of nasopharyngeal carcinoma].
    Liu L; Yao J; Ding Q; Cao R; Wang J; Huang S
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2005 Oct; 19(20):929-31. PubMed ID: 16398048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.
    Karagöz B; Bilgi O; Gümüs M; Erikçi AA; Sayan O; Türken O; Kandemir EG; Oztürk A; Yaylaci M
    Med Oncol; 2010 Mar; 27(1):29-33. PubMed ID: 19148592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CD4+ CD25high regulatory T cells in peripheral blood of patients with B cell non-Hodgkin's lymphoma].
    Liu L; Yao JX; Ding Q; Huang SA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Feb; 14(1):119-22. PubMed ID: 16584606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD4(+)CD25high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers.
    Kono K; Kawaida H; Takahashi A; Sugai H; Mimura K; Miyagawa N; Omata H; Fujii H
    Cancer Immunol Immunother; 2006 Sep; 55(9):1064-71. PubMed ID: 16328385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD4+CD25high regulatory cells in peripheral blood of cancer patients.
    Liu L; Wu G; Yao JX; Ding Q; Huang SA
    Neuro Endocrinol Lett; 2008 Apr; 29(2):240-5. PubMed ID: 18404145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes of CD4+CD25+FOXP3+ and CD8+CD28- regulatory T cells in non-small cell lung cancer patients undergoing surgery.
    Chen C; Chen D; Zhang Y; Chen Z; Zhu W; Zhang B; Wang Z; Le H
    Int Immunopharmacol; 2014 Feb; 18(2):255-61. PubMed ID: 24345703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia.
    Toldi G; Saito S; Shima T; Halmos A; Veresh Z; Vásárhelyi B; Rigó J; Molvarec A
    Am J Reprod Immunol; 2012 Aug; 68(2):175-80. PubMed ID: 22510013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4 CD25high regulatory T cells are not impaired in patients with primary Sjögren's syndrome.
    Gottenberg JE; Lavie F; Abbed K; Gasnault J; Le Nevot E; Delfraissy JF; Taoufik Y; Mariette X
    J Autoimmun; 2005 May; 24(3):235-42. PubMed ID: 15848046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of FOXP3+ regulatory T-cells in peripheral blood of patients with NSCLC.
    Li L; Chao QG; Ping LZ; Xue C; Xia ZY; Qian D; Shi-ang H
    Cancer Biother Radiopharm; 2009 Jun; 24(3):357-67. PubMed ID: 19538059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+CD25high T cells are enriched in the tumor and peripheral blood of prostate cancer patients.
    Miller AM; Lundberg K; Ozenci V; Banham AH; Hellström M; Egevad L; Pisa P
    J Immunol; 2006 Nov; 177(10):7398-405. PubMed ID: 17082659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variation of blood T lymphocyte subgroups in patients with non- small cell lung cancer.
    Wang WJ; Tao Z; Gu W; Sun LH
    Asian Pac J Cancer Prev; 2013; 14(8):4671-3. PubMed ID: 24083723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral glucocorticoid therapy on CD4+CD25+CD127- and CD4+CD25high T cell levels in asthmatic patients.
    Moniuszko M; Bodzenta-Lukaszyk A; Dabrowska M
    Inflammation; 2010 Dec; 33(6):415-20. PubMed ID: 20300815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral blood.
    Lawson CA; Brown AK; Bejarano V; Douglas SH; Burgoyne CH; Greenstein AS; Boylston AW; Emery P; Ponchel F; Isaacs JD
    Rheumatology (Oxford); 2006 Oct; 45(10):1210-7. PubMed ID: 16571607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4+CD25+ regulatory T cells in the peripheral blood of patients with breast cancer and non-small cell lung cancer.
    Okita R; Saeki T; Takashima S; Yamaguchi Y; Toge T
    Oncol Rep; 2005 Nov; 14(5):1269-73. PubMed ID: 16211295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of CD4+ CD25+ CD127(low/-) T cells in patients with systemic lupus erythematosus].
    Zhao SS; Li XM; Li XP; Zhai ZM; Chen Z; Ma Y; Zhang H; Zheng SG
    Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(7):453-6. PubMed ID: 18642784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating regulatory T cells inhibit endogenous cytotoxic T cell responses to lung adenocarcinoma.
    Ganesan AP; Johansson M; Ruffell B; Yagui-Beltrán A; Lau J; Jablons DM; Coussens LM
    J Immunol; 2013 Aug; 191(4):2009-17. PubMed ID: 23851682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of peripheral regulatory T cells in non-small cell lung cancer patients undergoing radiotherapy.
    Liu C; Wu S; Meng X; Liu G; Chen D; Cong Y; Shen G; Sun B; Wang W; Wang Q; Gao H; Liu X
    Oncotarget; 2017 Jun; 8(26):43427-43438. PubMed ID: 28624781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between CD4+CD25+ Treg and expression of HIF-1α and Ki-67 in NSCLC patients.
    He LY; Li L; Guo ML; Zhang Y; Zhang HZ
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1351-5. PubMed ID: 25967708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Circulating T Follicular Helper Cells and Regulatory Cells in Non-Small Cell Lung Cancer Patients.
    Guo Z; Liang H; Xu Y; Liu L; Ren X; Zhang S; Wei S; Xu P
    Scand J Immunol; 2017 Aug; 86(2):107-112. PubMed ID: 28513867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.